Hybio Pharmaceutical Market Cap

Hybio Pharmaceutical has a market cap or net worth of 19.52 billion as of April 28, 2026. Its market cap has increased by 46.84% in one year.

Market Cap

19.52B

Enterprise Value

21.33B

Revenue

898.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

22.10

Market Cap Chart

Since April 7, 2011, Hybio Pharmaceutical's market cap has increased from 2.93B to 19.52B, an increase of 566.20%. That is a compound annual growth rate of 13.41%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	19.78B	25.08%
Dec 31, 2025	15.81B	38.87%
Dec 31, 2024	11.38B	-5.08%
Dec 29, 2023	11.99B	-22.75%
Dec 30, 2022	15.53B	39.41%
Dec 31, 2021	11.14B	88.22%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Nhwa Pharmaceutical Co., LTD	22.08B
Tasly Pharmaceutical Group	21.84B
Apeloa Pharmaceutical Co.,Ltd	21.16B
Jilin Aodong Pharmaceutical Group	20.86B
Betta Pharmaceuticals	20.79B
Wedge Industrial	19.86B
Joincare Pharmaceutical Group Industry	19.42B
Walvax Biotechnology	19.00B

Market Cap Rankings